London's popular biotechnology event aimed at the broader European region to expedite the progress of biotechnology for revolutionising medical & healthcare sectors globally. The event will host a world-class exhibition […]
ACHEMA is home to the full scope of technology and services for the process industry. Fast gaining popularity among European and international audiences, it is a nextgen innovation and technology […]
MEDICAL CONFERENCES 2024, the premier event for medical technology, is set to take place in London, UK. This comprehensive event includes a major medtech exhibition and a medical device conference, offering a platform for showcasing innovations and discussing industry trends. The keynote speakers and agenda for the Digital Health World Congress 2024, featuring prominent organizations such as eMed, UBS, NOVARTIS, HUMA, Oracle, and EY. Attendees will have the opportunity to engage with leading experts, explore cutting-edge technologies, and gain valuable insights into the future of medical technology.
Gene and Cell Therapy Over 300 industry pioneers come together at World Asia, a premier event that has been held annually since 2017, to develop regenerative medicine and cell and gene therapy in Asia. The focus of this year's conference will be on innovations, manufacturing best practices, methods for scaling up, cost optimization, next-generation CAR-T medicines, and getting ready for commercialization. Prominent businesses including Tessa Therapeutics, Fosun Kite Biotechnology, BeiGene, and Gracell Biotechnologies will share their knowledge with attendees. The program provides a thorough examination of the most recent advancements in R&D, manufacturing, and commercialization. Come network with leading industry figures, discover state-of-the-art developments, and interact with unique case studies—all under one roof.
The 3rd Biologics Contract Manufacturing Asia 2024 is a premier event dedicated solely to contract manufacturing in Asia-Pacific. The conference discusses the rising contract manufacturing market, expected market trends, issues faced by CMOs/CDMOs, and future solutions and prospects. We bring together the entire ecosystem — from biologics manufacturing professionals to academia and regulators — to establish relationships, share insights, and stay ahead of future developments.
Gathering more than 300 industry pioneers, Cell & Gene Therapy World Asia has been a premier event since 2017. The goal of the conference is to promote research, development, and production of high-quality regenerative medicines and cell and gene treatments across Asia. This year's event will address the following topics: next-generation CAR-T medicines, advancements in CAR-T manufacturing, best practices in the region, scale-out strategies, cost optimization, commercialization readiness, and regulatory case studies.
Come network with influential people and up-and-coming businesses including Fosun Kite Biotechnology, Gracell Biotechnologies, BeiGene, and more. All under one roof, learn about the most recent advancements in R&D and commercialization, as well as industry demands and special case studies.
AI in Industries series at IIM Bangalore is focused on AI applications in various industrial sectors. The first theme is AI in Healthcare.
Eminence Business Media is happy to present the 2nd Annual Pharma Impurity Conclave 2024, which will address significant difficulties in medication impurity management, including the critical issue of nitrosamines. This event provides practical solutions, detailed case studies, and the most recent impurity profiling updates to help pharmaceutical professionals improve safety and efficacy standards. Attendees will learn vital insights from industry experts and discover new methods for addressing increasing R&D difficulties in medication formulation.
An overview of the Ontario Institute for Cancer Research's (OICR) principal programs, technological resources, research strategy, and international relationships will be provided by Dr. Laszlo Radvanyi, OICR President and Scientific Director. More than 325 researchers working in the fields of cancer genetics, molecular biology, biomarker development, and population health studies are housed at OICR, a leading Canadian cancer research funding organization, in Toronto. The goal of the institute is to improve cancer management and prevent relapse by translating state-of-the-art findings into practical applications, with a focus on liquid biopsies, precision oncology, and medicines. In addition, Dr. Radvanyi will discuss findings from his investigation into the function of retrotransposable elements in cancer, emphasizing new pathways and potential treatment targets.
As AI and data analytics are rebuilding the face of healthcare, this session will outline the huge opportunities AI opens to product managers and leaders in healthcare, med tech, and pharma; challenges that come with its adoption; and practical ways to make it successful. Hear from experts how to use AI and data to drive innovation in digital health, improve patient outcomes, and enhance operational efficiency.
AI will unlock new avenues to improve patient care and operational efficiency, provided that actionable solutions are presented for the technical, ethical, and regulatory challenges. Further, participants will learn how to leverage data insights to develop state-of-the-art digital health solutions that answer market demands and ensure compliance.
